Meet our Invited speaker

Dr. Pascal MAYER, CEO Alphanosos and Honorary Chair at University of Strasbourg Institute for Advanced Study

Simplicity as a paradigm to turn the unthinkable into reality:

Breakthroughs need to be thought before reduction-to-practice. In my case, such thought processes are surprisingly and humbly nearly fully related to a succession of otherwise unconnected educational and professional prior experiences. They lead me from next-generation DNA sequencing for drug-target discovery to next generation therapeutics which are sustainable, safe and efficient. These developments integrate AI as a key enabling technology.